These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 34211187)

  • 1. Immunomodulation by radiotherapy in tumour control and normal tissue toxicity.
    Cytlak UM; Dyer DP; Honeychurch J; Williams KJ; Travis MA; Illidge TM
    Nat Rev Immunol; 2022 Feb; 22(2):124-138. PubMed ID: 34211187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
    Walshaw RC; Honeychurch J; Illidge TM
    Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimism surrounding stereotactic body radiation therapy and immunomodulation.
    Tharmalingam H; Hoskin PJ
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S9. PubMed ID: 28917247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy.
    Guan H; Zhou Z; Hou X; Zhang F; Zhao J; Hu K
    Asia Pac J Clin Oncol; 2023 Feb; 19(1):35-50. PubMed ID: 35538049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.
    Colton M; Cheadle EJ; Honeychurch J; Illidge TM
    Radiat Oncol; 2020 Nov; 15(1):254. PubMed ID: 33148287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abscopal effect of radiotherapy combined with immune checkpoint inhibitors.
    Liu Y; Dong Y; Kong L; Shi F; Zhu H; Yu J
    J Hematol Oncol; 2018 Aug; 11(1):104. PubMed ID: 30115069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of CC chemokines in response to radiation.
    Wang L; Jiang J; Chen Y; Jia Q; Chu Q
    Radiat Oncol; 2022 Apr; 17(1):63. PubMed ID: 35365161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD73/Ado System-A New Player in RT Induced Adverse Late Effects.
    de Leve S; Wirsdörfer F; Jendrossek V
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31623231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
    Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of exosomes in tumour immunity under radiotherapy: eliciting abscopal effects?
    Yin T; Xin H; Yu J; Teng F
    Biomark Res; 2021 Mar; 9(1):22. PubMed ID: 33789758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker.
    Baxevanis CN; Gritzapis AD; Voutsas IF; Batsaki P; Goulielmaki M; Adamaki M; Zoumpourlis V; Fortis SP
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Effects of Radiotherapy on the Tumour Immune Microenvironment to Identify Potential Prognostic and Predictive Biomarkers of Radiotherapy Response.
    Cheng S; Cheadle EJ; Illidge TM
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33008040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic immune niches for cancer immunotherapy.
    Weiden J; Tel J; Figdor CG
    Nat Rev Immunol; 2018 Mar; 18(3):212-219. PubMed ID: 28853444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma.
    Donlon NE; Davern M; O'Connell F; Sheppard A; Heeran A; Bhardwaj A; Butler C; Narayanasamy R; Donohoe C; Phelan JJ; Lynam-Lennon N; Dunne MR; Maher S; O'Sullivan J; Reynolds JV; Lysaght J
    World J Gastroenterol; 2022 Jun; 28(21):2302-2319. PubMed ID: 35800186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming TGFβ-mediated immune evasion in cancer.
    Tauriello DVF; Sancho E; Batlle E
    Nat Rev Cancer; 2022 Jan; 22(1):25-44. PubMed ID: 34671117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade.
    Zhao X; Shao C
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy-immunotherapy combinations - perspectives and challenges.
    Mondini M; Levy A; Meziani L; Milliat F; Deutsch E
    Mol Oncol; 2020 Jul; 14(7):1529-1537. PubMed ID: 32112478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective.
    Nixon BG; Gao S; Wang X; Li MO
    Nat Rev Immunol; 2023 Jun; 23(6):346-362. PubMed ID: 36380023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
    Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.